Texas A.G. Paxton to Investigate Promotion of Puberty Blockers in Children
December 14, 2021
December 14, 2021
AUSTIN, Texas, Dec. 14 -- Texas Attorney General Ken Paxton issued the following news release:
Attorney General Ken Paxton is investigating Endo Pharmaceuticals, Inc., and AbbVie Inc. under the Texas Deceptive Trade Practices Act. These pharmaceutical companies allegedly advertised and promoted hormone (puberty) blockers for unapproved uses without disclosing the potential risks associated with these drugs to children and their parents.
Medications Supprelin LA and Lupr . . .
Attorney General Ken Paxton is investigating Endo Pharmaceuticals, Inc., and AbbVie Inc. under the Texas Deceptive Trade Practices Act. These pharmaceutical companies allegedly advertised and promoted hormone (puberty) blockers for unapproved uses without disclosing the potential risks associated with these drugs to children and their parents.
Medications Supprelin LA and Lupr . . .